TrademarkDir
ELASTATHERAPY
LIVE

Serial Number

79205352

Owner

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

Filing Date

Jan 18, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ELASTATHERAPY Trademark

Serial Number: 79205352 • Registration: 5398619

ELASTATHERAPY is a trademark filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED on January 18, 2017. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (253 trademarks)

CLONSHAUGH BUSINESS & TECHNOLOGY PARK
COOLOCK, DUBLIN 17 , IE

Entity Type: 77

Elastagen Pty Ltd (3 trademarks)

Australian Technology Park
EVELEIGH, NSW 2015 , AU

Entity Type: 99

Trademark Details

Filing Date

January 18, 2017

Registration Date

February 13, 2018

Published for Opposition

November 28, 2017

Cancellation Date

August 30, 2024

Goods & Services

Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations

Cosmetics in the form of gels, foams, creams, lotions, milks and powders; cosmetic preparations; skin moisturizers

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Sep 5, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 16, 2025 INTS
INVALIDATION PROCESSED
Aug 16, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 30, 2025 INTR
CHANGE OF OWNER RECEIVED FROM IB
Sep 30, 2024 CHLD
CANCELLED SECTION 71
Aug 30, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 13, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2022 NREP
INTERNATIONAL REGISTRATION RENEWED
Dec 16, 2019 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 29, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 21, 2018 FICS
FINAL DISPOSITION PROCESSED
May 21, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Dec 29, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 22, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 17, 2017 TCCA
REFUSAL PROCESSED BY IB
May 20, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 24, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 24, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 21, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 20, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 19, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 17, 2017 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 13, 2017 SDRC

Related Trademarks

More from this Owner

FOR A LIFT IN RELIEF

FOR A LIFT IN RELIEF

LO LOESTRIN FE

LO LOESTRIN FE

LO LOESTRIN FE

LO LOESTRIN FE

LO LOESTRIN FE

LO LOESTRIN FE

MIGRAINE ON THE MIND logo

MIGRAINE ON THE MIND

MIGRAINE ON THE MIND logo

MIGRAINE ON THE MIND